When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CELU - Why I Added Oncternal Therapeutics To My Watchlist
Celularity Inc.
Big Pharma has validated ROR1 therapies which are at the core of ONCT's oncology program.
Despite initial enthusiasm for ONCT, the market no longer assigns any premium to its stock.
Nonetheless, clinical results continue to be very positive, the company has engaged in additional partnerships, and its potential revenues are very meaningful relative to its miniscule enterprise value.
I have taken a "starter" position in the stock and will add to it on any further price decline.